MARKAZIY SEROZ XORIORETINOPATIYANI KOMPLEKS DAVOLASHDA MIKROIMPULSLI LAZER TA’SIRINING O‘RNI

Tuychibaeva D.M., Adhamova L.A.

Передовая Офтальмология · 2025-yil

Annotatsiya

Relevance. Among other retinopathies, central serous chorioretinopathy (CSC) ranks fourth in the incidence structure after age-related macular degeneration (AMD), diabetic retinopathy and retinal vein occlusion. Purpose of the study. To study the effectiveness of subthreshold micropulse laser exposure with a wavelength of 577 nm in the complex treatment of central serous chorioretinopathy. Materials and methods. The clinical study is based on the analysis of the CRC of 121 eyes of 121 patients with unilateral CSC. Among the subjects: 23 (19%) women and 98 (81%) men. The age of the participants was 40.8 ± 6.4 years. Results and conclusion. A protocol of SMLV with a wavelength of 577 nm was developed and introduced into clinical practice, which is safe and effective in the treatment of CSC. The absence of laser-induced damage when using the energy parameters of the SMLV protocol with a wavelength of 577 nmallows for treatment in the early acute period of CSC, in the phase of acute phase, with diffuse hyperfluorescence, and for repeating sessions during persistence and relapses of the process. Combined analysis of OCT, HF AF and IR-AF data allows for identifying the features of structural and functional changes in CRC in CSC, accurately determining the duration of the disease and predicting the functional outcome after the process has been resolved.

Maqola ma’lumotlari
MualliflarTuychibaeva D.M., Adhamova L.A.
JurnalПередовая Офтальмология
Nashr sanasi2025-06-16
Jild12
Son1
Betlar37-42
DOI10.57231/j.ao.2025.12.1.006

Передовая Офтальмология jurnalidan boshqa maqolalar

Передовая Офтальмология — barcha maqolalar